Prelude Therapeutics Announces IND Clearance for PRT2527, a High

PRLD: Prelude Therapeutics Incorporated
2021-11-08 09:00:00
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor
Beyond Technical Analysis

Declinazione di responsabilità